Introduction to mRNA Vaccine Trial
Researchers have reported that the latest drug trial involving an mRNA vaccine for melanoma represents a potential breakthrough in cancer treatment.
Patient Participation
Mark Orwig, a 73-year-old tennis coach residing in the San Francisco Bay Area, is among the international skin cancer patients participating in this innovative trial. The vaccine, leveraging messenger RNA technology, aims to combat cancer effectively.
Post-Surgery Concerns
In 2023, following the removal of a melanoma tumor from his cheek, Orwig faced uncertainties regarding his future health. Despite the surgery’s success, the risk that small cancerous cells might persist in the body posed a threat of recurrence, marking melanoma as a particularly deadly form of skin cancer.
Insights from a Hospital Executive’s Journey Working ER Shifts 
Biden Reflects on Memoir and Health Challenges 
Former Aide Criticizes Trump’s Advisers on Health Initiatives 
From Flight Attendant to Content Receptionist: Embracing Simplicity 
A Different Approach to Aging and Beauty 
Jocko Willink on Discipline and Longevity